The U.S. Food and Drug Administration (FDA) has officially launched a new inspection initiative known as One-Day Inspectional Assessments (ODIAs), signaling an important shift in how FDA-regulated companies may be inspected moving into 2026 and beyond. For manufacturers, exporters, and FDA-regulated businesses supplying products to the United States, this development reflects the FDA’s growing focus… Continue reading FDA One-Day Inspectional Assessments: What FDA-Regulated Companies Need to Know in 2026
Category: Regulatory Affairs
Health Canada LiquidFiles Transition 2026: Complete Compliance Guide for NHP Site Licence Submissions
What is the Health Canada LiquidFiles transition? The Health Canada LiquidFiles transition is the mandatory shift from ePost Connect to LiquidFiles for all Natural Health Product (NHP) site licence submissions, effective May 1, 2026.The transition to LiquidFiles by Health Canada marks a critical regulatory shift for Natural Health Product (NHP) companies in Canada. Effective May… Continue reading Health Canada LiquidFiles Transition 2026: Complete Compliance Guide for NHP Site Licence Submissions
FDA vs Health Canada Cosmetic Regulations: A Technical Comparison of Compliance Requirements for Cosmetic Products
Companies planning to commercialize cosmetic products in North America frequently target both the United States and Canada due to their large consumer markets and strong distribution networks. Although these markets are geographically close, cosmetic regulatory frameworks in the United States and Canada differ significantly in terms of ingredient restrictions, labeling requirements, facility obligations, and regulatory… Continue reading FDA vs Health Canada Cosmetic Regulations: A Technical Comparison of Compliance Requirements for Cosmetic Products